We are live on ! Find out more
OAM

Oppenheimer Asset Management Portfolio holdings

AUM $9.63B
1-Year Est. Return 30.32%
This Fund
S&P 500
This Quarter Est. Return
+3.85%
1 Year Est. Return
+30.32%
3 Year Est. Return
+85%
5 Year Est. Return
+99.62%
10 Year Est. Return
+601.29%
AUM
$4.53B
AUM Growth
+$74M
Cap. Flow
-$53.9M
Cap. Flow %
-1.19%
Top 10 Hldgs %
16.99%
Holding
1,686
New
82
Increased
587
Reduced
862
Closed
57

Sector Composition

Rank Sector Weight
1 Technology 15.3%
2 Financials 14.57%
3 Healthcare 12.35%
4 Industrials 9.68%
5 Consumer Discretionary 8.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SEI
1101
Solaris Energy Infrastructure
SEI
$3.55B
$159K ﹤0.01%
10,606
+528
+5% +$8.76K
DERM
1102
DELISTED
Dermira, Inc.
DERM
$158K ﹤0.01%
16,521
+2,797
+20% +$30.1K
P
1103
Everpure Inc
P
$29.9B
$157K ﹤0.01%
10,246
+885
+9% +$17.3K
UAL icon
1104
United Airlines
UAL
$42.1B
$157K ﹤0.01%
1,789
-195
-10% -$16.5K
STNE icon
1105
StoneCo
STNE
$2.58B
$156K ﹤0.01%
+5,289
New +$156K
GT icon
1106
Goodyear
GT
$1.85B
$155K ﹤0.01%
10,153
+1,507
+17% +$25.4K
ORA icon
1107
Ormat Technologies
ORA
$6.64B
$155K ﹤0.01%
2,447
-71
-3% -$4.23K
WAT icon
1108
Waters Corp
WAT
$39.9B
$155K ﹤0.01%
721
-16
-2% -$3.5K
MSCI icon
1109
MSCI
MSCI
$40.9B
$154K ﹤0.01%
644
-102
-14% -$22.9K
BSCP
1110
DELISTED
Invesco BulletShares 2025 Corporate Bond ETF
BSCP
$153K ﹤0.01%
7,236
-1,410
-16% -$29.2K
LEG icon
1111
Leggett & Platt
LEG
$1.31B
$153K ﹤0.01%
3,978
-6
-0.2% -$237
SCHA icon
1112
Schwab U.S Small- Cap ETF
SCHA
$23.1B
$153K ﹤0.01%
8,564
+8
+0.1% +$141
UTMD icon
1113
Utah Medical Products
UTMD
$225M
$153K ﹤0.01%
1,601
+158
+11% +$13.3K
JBGS
1114
JBG SMITH
JBGS
$708M
$152K ﹤0.01%
3,853
+213
+6% +$8.76K
SGMO
1115
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$151K ﹤0.01%
14,035
+1,003
+8% +$10.7K
DINO icon
1116
HF Sinclair
DINO
$14.5B
$150K ﹤0.01%
3,239
-225
-6% -$10.1K
QGEN icon
1117
Qiagen
QGEN
$8.72B
$150K ﹤0.01%
3,485
+85
+3% +$3.52K
IBDD
1118
DELISTED
iShares iBonds Mar 2023 Term Corporate ETF
IBDD
$150K ﹤0.01%
5,617
-1,087
-16% -$28.7K
NBLX
1119
DELISTED
Noble Midstream Partners LP
NBLX
$150K ﹤0.01%
4,504
+190
+4% +$6.42K
ARRY
1120
DELISTED
Array Biopharma Inc
ARRY
$149K ﹤0.01%
3,217
-25,553
-89% -$717K
BAC.PRL icon
1121
Bank of America Series L
BAC.PRL
$3.99B
$148K ﹤0.01%
108
+8
+8% +$10.6K
CRTO icon
1122
Criteo S.A. Ordinary Shares
CRTO
$923M
$148K ﹤0.01%
8,612
+1,534
+22% +$30.2K
TRNS icon
1123
Transcat
TRNS
$871M
$148K ﹤0.01%
5,788
+3,069
+113% +$75.2K
TLRA
1124
DELISTED
Telaria, Inc.
TLRA
$147K ﹤0.01%
+19,586
New +$147K
LPX icon
1125
Louisiana-Pacific
LPX
$5.49B
$146K ﹤0.01%
5,562
-930
-14% -$22.8K

Similar funds

Oppenheimer Asset Management's Q2 2019 Portfolio in Review

As of Q2 2019, Oppenheimer Asset Management held 1,686 positions worth $4.53B, up 1.7% from $4.45B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Oppenheimer Asset Management's Q2 2019 filing shows 82 new, 587 increased, 862 reduced and 57 closed positions. Its largest new stake was Dow Inc: 138,432 shares worth $6.83M. The largest sale was iShares MBS ETF, an estimated $11.6M.

By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 15% a quarter earlier, followed by Financials and Healthcare.

  • Oppenheimer Asset Management's largest Q2 2019 buy was Dow Inc: 138,432 shares worth $6.83M.
  • Oppenheimer Asset Management added most to State Street SPDR Bloomberg 1-3 Month T-Bill ETF in Q2 2019, an estimated $12.9M increase.
  • Oppenheimer Asset Management's biggest Q2 2019 reduction was iShares MBS ETF, cutting an estimated $11.6M.
  • Oppenheimer Asset Management fully exited Ultimate Software Group Inc in Q2 2019, selling an estimated $9.6M.
  • Oppenheimer Asset Management's ten largest holdings make up 17% of its $4.53B portfolio in Q2 2019.
  • Oppenheimer Asset Management opened 82 new positions and closed 57 in Q2 2019.
  • Oppenheimer Asset Management's portfolio value rose 1.7% quarter-over-quarter to $4.53B.

Based on Oppenheimer Asset Management's 13F filing for Q2 2019, filed 9 Aug 2019.